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Introduction: Metformin is a widely used type-2 diabetes drug. Its copper-binding properties are 
known to be crucial but still not fully understood. We present a comprehensive investigation of its 
interaction with L-cysteine-Cu complex using a magnetic microbead (MB)-based assay on a 
microfluidic disc. The assay scheme is similar to the one presented in our previous study, where 
optomagnetic readout and magnetic nanobeads were used [1]. In this study, we have 
significantly simplified the detection by using an optical scanning method [2] and micrometer-
sized beads. Additionally, we can measure the effect of 100-fold lower concentration of 
metformin than in our previous study. Our results clearly illustrate the strong metformin-Cu 
interaction and provide the opportunity of real-time analysis.  
 
Methods: 
 
              
 
 
 
 
 
The assay platform is a microfluidic disc made of Poly(methylmetacrylate) (PMMA) bonded 
together using pressure-sensitive adhesive (Fig.2a). For studying L-cysteine-Cu interaction, Cu 
solution and 1µm streptavidin-coated MBs (1mg/ml) functionalized with biotinylated L-cysteine 
(volume ratio 1:11) were incubated for 10 minutes with gentle shaking and then loaded into the 
disc. For studying interaction between metformin and L-cysteine-Cu complex, metformin was 
added to a separately pre-incubated L-cysteine-Cu (volume ratio 2:1) solution, further incubated 
for 5 minutes and loaded into the disc. Finally, all samples were incubated on-disc under 
permanent magnetic field with continuous shaking for 10 minutes before scanning by 
oCelloScope (Fig.2b).  
                                       
 
 
 
 
 
 
 
Results: Scanning results of four different samples are illustrated in Fig.3.  
Fig1: Streptavidin-coated MBs are functionalized with biotinylated L-cysteine. Addition of Cu
2+
 
molecules causes the formation of multiple L-cysteine-Cu complexes resulting in the 
formation of MB clusters. Addition of metformin breaks the L-cysteine-Cu complex causing 
the breakage of the clusters followed by formation of several metformin-Cu complexes. [1] 
 
Fig2: (a) Schematics of microfluidic disc with 18 pools. The disc format has been used for its 
rotational advantages during magnetic incubation and easy paralysation. (b) Optical scanning 
setup (oCelloScope, Philips Biocell) (c) Functional unit of oCelloScope [2]. It uses an optical 
sectioning principal by tilting the focal plane few degrees for recording series of images along 
the scan direction and forms an image stack resulting in capturing and characterizing all the 
objects of interest along all axes.  
 
                  
  
 
 
 
 
 
 
 
 
 
We performed real-time analysis of cluster formation as illustrated in Fig4.  
         
 
  
 
 
 
 
 
 
Discussion: The presented results show that metformin, even at low concentration, is able to 
break the L-cysteine-Cu complex, which can affect mitochondrial function [3]. The investigation 
provides in-depth insight on the metformin-Cu interactions by quantifying the size of the clusters 
formed by molecular reaction. Thus, the novel detection strategy and kinetics analysis could be 
used for studying metal-binding properties of metformin-analogues.  
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Fig3: (a) Magnetic beads functionalized with biotinylated L-cysteine used as the control 
sample (b) L-cysteine functionalized MBs incubated in Cu solution followed by 10min 
magnetic incubation. MB clusters form because of the formation of L-cysteine-Cu complex. 
(c) & (d) After the addition of 2.1µM and 21µM metformin into two separate mixtures of Cu 
and L-cysteine functionalized MB followed by magnetic incubation, the MB-clusters are 
broken in respective order for the breakage of L-cysteine-Cu complex and formation of 
metformin-Cu complex. (e) Measured MB cluster size vs amount of metformin in the sample: 
we conclude that samples with 21µM and 2.1 µM metformin have 57.9% and 34.6% reduced 
mean cluster size respectively than the sample with only Cu. Scale bar: 50µm. 
 
 
Fig4: L-cysteine coupled MBs were incubated in Cu
2+
 solution for 15 minutes, which resulted 
in an insignificant visible change in size of particles. Magnetic incubation for 10 mins resulted 
in the formation of large clusters (mean area: 233.68µm
2
) which shows the significance of an 
optimized magnetic incubation. Next, 5 mins incubation with metformin followed by 10 min 
magnetic incubation showed MB clusters of about 94.24µm
2 
mean area i.e. addition of 
metformin caused 40% averaged reduction of the L-cysteine-Cu-MB  cluster size. Additional 
incubation of 15 mins was performed showing no significant changes.  
 
 
